Antifungal resistance in opportunistic candidiasis: challenges and risks to global public health
Main Article Content
Downloads
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.References
Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2017;3(4):57. https://doi.org/10.3390/jof3040057
Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024; 24(7):e428-e438. https://doi.org/10.1016/S1473-3099(23)00692-8
Rodrigues ML. Negligenciadas entre as negligenciadas: perspectiva de prevenção, controle e diagnóstico de doenças causadas por fungos. Rio de Janeiro: Fundação Oswaldo Cruz; 2019.
Hamburger FG, Gales AC, Colombo AL. Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries. Mycopathologia. 2024;189(4):60. https://doi.org/10.1007/s11046-024-00867-w
World Health Organization (WHO). WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022.